PGNY Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
350.5M
+6.7%
328.5M
+3.2%
318.4M
+1.6%
313.3M
-5.9%
332.9M
Cost of Revenue
261.2M
+6.4%
245.4M
+1.6%
241.5M
+0.4%
240.5M
-5.3%
253.9M
Gross Profit
89.3M
+7.5%
83.1M
+8.1%
76.9M
+5.6%
72.8M
-7.8%
79.0M
Operating Expenses
49.3M
+3.4%
47.7M
-22.7%
61.7M
+20.2%
51.3M
-6.1%
54.6M
R&D
0
0
0
0
0
SG&A
49.3M
+3.4%
47.7M
-22.7%
61.7M
+20.2%
51.3M
-6.1%
54.6M
Operating Income
40.0M
+13.1%
35.4M
+132.4%
15.2M
-29.3%
21.5M
-11.6%
24.4M
EBITDA
41.6M
+12.9%
36.9M
+122.2%
16.6M
-22.9%
21.5M
-15.8%
25.6M
Net Income
28.1M
+15.8%
24.2M
+94.1%
12.5M
-9.9%
13.9M
-19.0%
17.1M
EPS (Basic)
$0.36
+20.0%
$0.30
+100.0%
$0.15
-6.3%
$0.16
-20.0%
$0.20
EPS (Diluted)
$0.34
+17.2%
$0.29
+107.1%
$0.14
-6.7%
$0.15
-21.1%
$0.19
Shares (Diluted)
82.1M
-3.1%
84.8M
-5.3%
89.5M
-0.8%
90.2M
+0.7%
89.6M
Progyny (PGNY) โ€” Financials